PuraPharm Corporation Limited (HKG:1498)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
0.2800
+0.0050 (1.82%)
Jul 31, 2026, 4:08 PM HKT

PuraPharm Corporation Financials Overview

Millions HKD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
336.11336.11382.09406.86448.07659.59
Revenue Growth
-3.07%-12.03%-6.09%-9.20%-32.07%9.60%
Gross Profit
180.16180.16205.14216.63262.7423.35
Operating Income
-16.22-16.22-18.25-53.2-68.2515.14
Net Income
-35.22-35.22-35.44-106.08-120.21-121.88
Earnings Per Share
-0.08-0.08-0.09-0.27-0.30-0.31
EPS Growth
------

Revenue by Segment

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Hong Kong CCMG
204.95204.95212.49215.47199.41170.64
Chinese Healthcare Products
96.9796.9785.9183.5879.2879.09
Clinics
51.2451.2456.3153.7346.1150.03
Plantation
175.97175.97183.9837.6189.5344.83
Elimination
-193.01-193.01-156.59-156.33-208.51-136.05
Total
336.11336.11382.09406.86448.07659.59

Cash & Debt

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
35.935.936.942.9891.3696.06
Total Debt
351.14351.14363.76424.77503.16531.96
Net Cash (Debt)
-315.25-315.25-326.86-381.8-411.8-435.9
Net Cash Growth
------
Net Cash Per Share
-0.75-0.75-0.83-0.97-1.04-1.11

Cash Flow & CapEx

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
28.5328.53103.9979.6188.51-14.52
Capital Expenditures
-0.28-0.28-14.81-19.18-20.83-3.09
Free Cash Flow
28.2428.2489.1860.4367.68-17.61
Free Cash Flow Growth
-64.33%-68.33%47.58%-10.72%--

Margins

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
53.60%53.60%53.69%53.24%58.63%64.18%
Operating Margin
-4.83%-4.83%-4.78%-13.08%-15.23%2.30%
Pretax Margin
-10.24%-10.24%-7.63%-25.15%-26.60%-17.77%
Profit Margin
-10.48%-10.48%-9.28%-26.07%-26.83%-18.48%
FCF Margin
8.40%8.40%23.34%14.85%15.10%-2.67%

Valuation

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Forward PE
-13.3313.3313.3313.3313.33
P/FCF Ratio
5.306.732.445.887.47-
PS Ratio
0.450.560.570.871.130.48